Calcitonin Treatment of Hypercalcemia Due to Parathyroid Carcinoma: Synergistic Effect of Prednisone on Long-Term Treatment of Hypercalcemia

Archives of Internal Medicine

Volumn 135, Issue 12, 1975, Pages 1594-1597

  Au, William Y W ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PREDNISONE;

DRUG THERAPY; HYPERCALCEMIA; MAJOR CLINICAL STUDY; MOBECARB; PARATHYROID CARCINOMA; THERAPY;

ADULT; BONE RESORPTION; CALCITONIN; CALCIUM; CASE REPORT; DRUG SYNERGISM; HUMAN; HYPERCALCEMIA; MALE; NEOPLASM METASTASIS; PARATHYROID NEOPLASMS; PLICAMYCIN; PREDNISONE; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0016770853     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1975.00330120072010     Document Type: Note

References (14)

1. Goldsmith RS, Ingbar SH: Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med 274:1-7, 1966.
2. Fulmer DH, Dimich AB, Rothschild EO, et al: Treatment of hypercalcemia. Arch Intern Med 129:923-930, 1972.
3. Singer FR, Neer RM, Murray TM, et al: Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma. N Engl J Med 283:634-636, 1970.
4. Neer RM, Habener JF, Peacock N, et al: Escape from calcitonin (CT) during therapy of hypercalcemia. Clin Res 18:676, 1970.
5. Raisz LG, Au WYW, Friedman J, et al: Thyrocalcitonin and bone resorption. Am J Med 43:684-690, 1967.
6. Wener JA, Gorton SJ, Raisz LG: Escape from inhibition of resorption in cultures of fetal bone treated with calcitonin and parathyroid hormone. Endocrinology 90:752-759, 1972.
7. Dube WJ, Goldsmith RS, Arnaud SB, et al: Hyperparathyroidism secondary to long-term therapy of Paget's disease of bone with calcitonin, in Talmage RV, Munson PL (eds): Calcium, Parathyroid Hormone and the Calcitonins. Amsterdam, Excerpta Medica, 1972, pp 113-115.
8. Singer FR, Aldred JP, Neer RM, et al: An evaluation of antibodies and clinical resistance to salmon calcitonin. J Clin Invest 51:2331-2338, 1972.
9. Raisz LG, Wener JA, Trummel CL, et al: Induction, inhibition and escape as phenomena of bone resorption, in Talmage RV, Munson PL (eds): Calcium, Parathyroid Hormone and the Calcitonins. Amsterdam, Excerpta Medica, 1972, pp 446-453.
10. Conaway HH, Anast CS: Double antibody radioimmunoassay for parathyroid hormone. J Lab Clin Med 83:129-138, 1974.
11. Silva OL, Becker KL: Salmon calcitonin in the treatment of hypercalcemia. Arch Intern Med 132:337-339, 1973.
12. Pak CYC, Mills MR, Smith GW II, et al: Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma. J Clin Endocrinol Metab 28:1657-1660, 1968.
13. Hill CS Jr, Ouais SG, Leiser AE: Long-term administration of calcitonin for hypercalcemia secondary to recurrent parathyroid carcinoma. Cancer 29:1016-1020, 1972.
14. Raisz LG: The pharmacology of bone. Rational Drug Ther 5:1-7, 1971.